Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-390MR vs AG-1749 in erosive esophagitis (Phase II/III)
jRCT2080220529Phase 3
- Sponsor
- Takeda
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexlansoprazole in erosive esophagitis (EE) (2 arms), sponsored by Takeda.
02
Drugs
dexlansoprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on jRCT2080220529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220529.